Financial information, reports, calendar and more
Annual Reports
2021
Årsredovisning 2021 (Swedish), March 15, 2022
Annual Report 2021, March 15, 2022
2020
Årsredovisning 2020 (Swedish), June 29, 2021
2019
Årsredovisning 2019 (Swedish) – June 2, 2020
2018
Årsredovisning 2018 (Swedish) – June 4, 2019
2017
Årsredovisning 2017 (Swedish) – May 23, 2018
2016
Årsredovisning 2016 (Swedish) – June 8, 2017
2015
Årsredovisning 2015 (Swedish) – April 29, 2016
2014
Årsredovisning 2014 (Swedish) – June 2, 2015
2013
Årsredovisning 2013 (Swedish) – April 17, 2014
Affibodys latest Press releases
2023-01-05
Positive Top-line Clinical Data for Izokibep in Hidradenitis Suppurativa
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)